Insider Trading Revealed: Analyzing Cambiar Investors LLC Q3 2022 vs. Q4 2022 13F Holdings
Ava Hoppe | 5 May, 2023
In the corporate world, insider trading is a term used to define the buying or selling of securities using non-public information. This type of unethical practice allows an individual or a group of people to gain an unfair advantage over other investors. However, when insiders disclose their transactions and holdings to the Securities and Exchange Commission (SEC) through the 13F filing, their activities become public knowledge, allowing individuals to analyze and see the big picture of significant changes.
In this article, we will delve into the world of insider trading by analyzing the 13F filings of Cambiar Investors LLC Q3 2022 vs. Q4 2022 holdings comparison. Cambiar is a registered investment advisor that specializes in managing a portfolio of stocks. Through the comprehensive analysis of the holdings data obtained from the SEC filings, we aim to provide valuable insights into the stock movements of Cambiar Investors and how it may affect other investors.
According to the data, Cambiar Investors LLC sold 70,650 shares of the RAYTHEON TECHNOLOGIES CORP (RTX) stock, reducing their holdings by 8.8%. The company also reduced its holdings of JPMORGAN CHASE & CO (JPM) by 24.7% and sold 84.4% of its AMERICAN EXPRESS CO (AXP) stock, replacing them with new investments such as CHUBB LIMITED (CB) and CONSTELLATION BRANDS INC (STZ). These shifts in holdings indicate that Cambiar is reallocating their investments to take advantage of new opportunities and trends in the stock market.
Other notable changes in Cambiar Investors' portfolio include a significant increase in shares of CENTENE CORP DEL (CNC) by 47.2% and a 42.2% increase in MEDTRONIC PLC (MDT) stocks. In contrast, the company sold 31.9% of its MOTOROLA SOLUTIONS INC (MSI) shares, reducing its investment to less than half its previous holdings.
It's worth noting that Cambiar Investors' portfolio is diverse, featuring stocks from various industries such as healthcare, technology, and finance. The company invested in different companies, including NOVARTIS AG (NVS), BURLINGTON STORES INC (BURL), and REINSURANCE GRP OF AMERICA I (RGA).
In conclusion, analyzing the 13F filings of Cambiar Investors LLC Q3 2022 vs. Q4 2022 holdings comparison can provide investors with valuable insights on insider trading activities. While these filings are not regulatory in nature, they can help investors make informed decisions about their investments and offer a glimpse into the broader investment landscape. As always, investors should do their own research, seek professional advice, and stay up-to-date with regulatory requirements.
Other Posts
- Korbyt Anywhere℠: Expanding Workplace Communication through Zoom App Marketplace
- Bridging Growth and Sustainability: Adenia's $470M Fund Lights Up African Investment Landscape
- Analyzing Tradition Capital Management LLC's Q4 2018 vs. Q1 2019 13F Holdings Report
- Navigating the Changes in the Financial Advisory Group's Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Investment Shifts: SFE Investment Counsel Q3 2022 vs. Q4 2022
- Navigating the Waves of Change: Vanguard Capital's Investment Shifts from Late 2023 to Early 2024
- Windsor Capital Management, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Brandes Investment Partners' Q3 vs. Q4 2022 13F Holdings Comparison: Insights into Changes in Holdings Over the Past Quarter.
- Folger Nolan Fleming Douglas Capital Management Q1 2023: An In-Depth Look into Their 13F Holdings
- Chatham Capital Group, Inc. Q3 2023 vs. Q4 2023 13F Holdings Comparison